127 related articles for article (PubMed ID: 29061815)
1. Orlistat Reduces Proliferation and Enhances Apoptosis in Human Pancreatic Cancer Cells (PANC-1).
Sokolowska E; Presler M; Goyke E; Milczarek R; Swierczynski J; Sledzinski T
Anticancer Res; 2017 Nov; 37(11):6321-6327. PubMed ID: 29061815
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
Grube S; Dünisch P; Freitag D; Klausnitzer M; Sakr Y; Walter J; Kalff R; Ewald C
J Neurooncol; 2014 Jun; 118(2):277-287. PubMed ID: 24789255
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
Yoshii Y; Furukawa T; Oyama N; Hasegawa Y; Kiyono Y; Nishii R; Waki A; Tsuji AB; Sogawa C; Wakizaka H; Fukumura T; Yoshii H; Fujibayashi Y; Lewis JS; Saga T
PLoS One; 2013; 8(5):e64570. PubMed ID: 23741342
[TBL] [Abstract][Full Text] [Related]
4. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747
[TBL] [Abstract][Full Text] [Related]
6. The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas.
Agostini M; Almeida LY; Bastos DC; Ortega RM; Moreira FS; Seguin F; Zecchin KG; Raposo HF; Oliveira HC; Amoêdo ND; Salo T; Coletta RD; Graner E
Mol Cancer Ther; 2014 Mar; 13(3):585-95. PubMed ID: 24362464
[TBL] [Abstract][Full Text] [Related]
7. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
[TBL] [Abstract][Full Text] [Related]
8. Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Schcolnik-Cabrera A; Chávez-Blanco A; Domínguez-Gómez G; Taja-Chayeb L; Morales-Barcenas R; Trejo-Becerril C; Perez-Cardenas E; Gonzalez-Fierro A; Dueñas-González A
Expert Opin Investig Drugs; 2018 May; 27(5):475-489. PubMed ID: 29723075
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-Substituted Benzothiazole Derivatives and Their
Uremis N; Uremis MM; Tolun FI; Ceylan M; Doganer A; Kurt AH
Anticancer Res; 2017 Nov; 37(11):6381-6389. PubMed ID: 29061823
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
Carvalho MA; Zecchin KG; Seguin F; Bastos DC; Agostini M; Rangel AL; Veiga SS; Raposo HF; Oliveira HC; Loda M; Coletta RD; Graner E
Int J Cancer; 2008 Dec; 123(11):2557-65. PubMed ID: 18770866
[TBL] [Abstract][Full Text] [Related]
11. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
12. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
Johnson JL; de Mejia EG
Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal.
Chuang HY; Chang YF; Hwang JJ
Biomed Pharmacother; 2011 Jul; 65(4):286-92. PubMed ID: 21723078
[TBL] [Abstract][Full Text] [Related]
14. Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat.
Huang HQ; Tang J; Zhou ST; Yi T; Peng HL; Shen GB; Xie N; Huang K; Yang T; Wu JH; Huang CH; Wei YQ; Zhao X
Int J Oncol; 2012 Aug; 41(2):523-32. PubMed ID: 22581080
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.
Deepa PR; Vandhana S; Jayanthi U; Krishnakumar S
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):494-503. PubMed ID: 22151915
[TBL] [Abstract][Full Text] [Related]
16. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.
Zhao G; Cui J; Zhang JG; Qin Q; Chen Q; Yin T; Deng SC; Liu Y; Liu L; Wang B; Tian K; Wang GB; Wang CY
Gene Ther; 2011 Sep; 18(9):920-8. PubMed ID: 21677689
[TBL] [Abstract][Full Text] [Related]
18.
Czumaj A; Zabielska J; Pakiet A; Mika A; Rostkowska O; Makarewicz W; Kobiela J; Sledzinski T; Stelmanska E
Anticancer Res; 2019 Jul; 39(7):3815-3822. PubMed ID: 31262909
[TBL] [Abstract][Full Text] [Related]
19. N,N'-di-(m-methylphenyi)-3,6-dimethyl-1,4-dihydro-1,2,4,5-tetrazine-1,4-dicarboamide (ZGDHu-1) suppresses the proliferation of PANC-1 pancreatic cancer cells via apoptosis and G2/M cell cycle arrest.
Chen SF; Xia J; Lv YP; Liu JL; Li WX; Yu XP; Hu WX; Zhou YL
Oncol Rep; 2015 Apr; 33(4):1915-21. PubMed ID: 25683065
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis.
Díaz Osterman CJ; Gonda A; Stiff T; Sigaran U; Valenzuela MM; Ferguson Bennit HR; Moyron RB; Khan S; Wall NR
Pancreas; 2016 Jan; 45(1):101-9. PubMed ID: 26348467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]